Literature DB >> 3144212

The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs.

P A Hutson1, S T Holgate, M K Church.   

Abstract

We describe the effects of the antiallergic drug cromolyn sodium and the beta 2-selective adrenoceptor agonist albuterol against early and late phase changes in specific airways conductance (sGaw) and leukocyte infiltration into the airways after allergen challenge of nonanesthetized guinea pigs. Inhalation of ovalbumin by sensitized guinea pigs induced three phases of airways obstruction: an early asthmatic response (EAR) peaking at 2 h, a late response (LAR) peaking at 17 h, and a further late response (LLAR) being observed at 72 h. The LAR was accompanied by a 13-fold rise in neutrophils and a four-fold rise in eosinophils recovered by bronchoalveolar lavage (BAL) at 17 h. By 72 h, the BAL content of neutrophils had returned to near normal, whereas eosinophil numbers had risen to 6.7-fold above baseline. Inhalation of an aerosolized solution of cromolyn, 10 mg/ml, 15 min before challenge inhibited both the EAR and LAR and the influx of neutrophils into the airways at 17 h but had no effect on eosinophil accumulation. Inhalation of cromolyn at 6 h, i.e., after the completion of the EAR, inhibited the LAR, the LLAR, and the rise in eosinophils at 72 h but did not reduce the influx of neutrophils at 17 h. Administration of cromolyn at both 15 min before and 6 h after challenge inhibited all changes in sGaw and reduced the accumulation of neutrophils at 17 h and the influx of eosinophils at 72 h. In contrast, inhalation of albuterol, 0.1 mg/ml, 15 min before allergen provocation blocked the EAR and the rise in BAL neutrophils at 17 h but did not inhibit the LAR. Inhalation of albuterol at 6 h partially reversed the LAR but had no effect on either the LLAR or cellular changes. Given at both times, albuterol inhibited the EAR and neutrophil accumulation at 17 h and partially reversed the LAR but produced no other effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144212     DOI: 10.1164/ajrccm/138.5.1157

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

1.  Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs.

Authors:  T Sugasawa; N Imanishi; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 3.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

4.  Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways.

Authors:  T Iwama; H Nagai; H Suda; N Tsuruoka; A Koda
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

5.  Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; K Boubekeur; I D Chapman; D Smith; M A Kings; J Morley
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

6.  The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration.

Authors:  G Cieslewicz; A Tomkinson; A Adler; C Duez; J Schwarze; K Takeda; K A Larson; J J Lee; C G Irvin; E W Gelfand
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.

Authors:  C J Whelan; M Johnson
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

8.  Inflammatory mediators and cellular infiltration of the lungs in a guinea pig model of the late asthmatic reaction.

Authors:  A F Walls; Y K Rhee; D J Gould; C Walters; C Robinson; M K Church; S T Holgate
Journal:  Lung       Date:  1991       Impact factor: 2.584

9.  Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; A Kristersson; D Smith; J Morley
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

10.  Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea-pigs.

Authors:  M Pretolani; J Lefort; D Leduc; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.